NPCE NeuroPace, Inc.

NASDAQ
$8.20

NeuroPace, Inc. (NPCE) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +31.2% since its last earnings release on November 12, 2026.

NeuroPace Missed Expectations, Lowers Guidance
Thursday, November 12, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.14) (GAAP)
Rev est $26.64M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $7.70

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About NeuroPace, Inc.

NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.